|
2.6 Etiologie - Environnement
|
|
|
|
3. Prévention
|
|
|
|
3.1 Prévention - Tabac
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
|
5. Traitements
|
|
|
Combination Rethink [Harvard Medical School]
|
|
|
|
|
|
This
finding differs from current hypotheses about drug interaction, which
have commonly explained benefits as arising from drug synergy. However,
this should not be interpreted as diminishing the value of combination
therapy for patients, the team cautions.
|
|
|
|
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
|
5.2 Pharma
|
|
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
|
Drug Industry Spent Millions To Squelch Talk About High Drug Prices [KHN]
|
|
|
|
|
|
The
$57 million PhRMA spent on lobbying was also the most since 2009, when
the lobbying bill was $70 million. So was the $7 million spent on
advertising, a cost that should rise this year, since the “Go Boldly”
ads aired in 2017. PhRMA employed 237 people last year, up from fewer
than 200 in 2011.
|
|
|
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
5.5 ASCO
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.10.1 Politiques (USA)
|
|
|